Citius Pharma Files Definitive Proxy Statement

Ticker: CTXR · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1506251

Sentiment: neutral

Topics: proxy-statement, annual-meeting, sec-filing

Related Tickers: CTRS

TL;DR

Citius Pharma (CTRS) proxy filing is out for June 9th meeting. Vote your shares!

AI Summary

Citius Pharmaceuticals, Inc. filed its Definitive Proxy Statement (DEF 14A) on April 28, 2025, for its annual meeting on June 9, 2025. The filing concerns the solicitation of proxies from shareholders regarding matters to be voted on at the meeting. The company, previously known as Trail One, Inc., is incorporated in Nevada and operates in the pharmaceutical preparations industry.

Why It Matters

This filing is crucial for shareholders as it outlines the agenda for the annual meeting and provides information necessary for them to cast their votes on important company matters.

Risk Assessment

Risk Level: low — This is a standard DEF 14A filing, which is a routine disclosure for public companies regarding their annual shareholder meetings.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this DEF 14A filing?

The purpose of this DEF 14A filing is to provide shareholders with information and solicit their proxies for the upcoming annual meeting of shareholders scheduled for June 9, 2025.

When is Citius Pharmaceuticals, Inc.'s annual shareholder meeting scheduled?

The annual shareholder meeting is scheduled for June 9, 2025.

What was Citius Pharmaceuticals, Inc. formerly known as?

Citius Pharmaceuticals, Inc. was formerly known as Trail One, Inc.

What is the company's Standard Industrial Classification (SIC) code?

The company's SIC code is 2834, which corresponds to Pharmaceutical Preparations.

Where is Citius Pharmaceuticals, Inc. incorporated?

Citius Pharmaceuticals, Inc. is incorporated in Nevada (NV).

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding Citius Pharmaceuticals, Inc. (CTXR).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing